Task: Answer the multiple-choice question.
Query: Which drug exhibits a 9.899% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1cccc(-c2cc(C(=O)NCC3CCCO3)c3cc(C)cc(C)c3n2)c1
b. Cc1ccc(NC(=O)N2CCSc3ccccc32)cc1
c. Cc1c(C(=O)N2CCCCC2C)sc2nc3n(c(=O)c12)CCC3
Answer: c. Cc1c(C(=O)N2CCCCC2C)sc2nc3n(c(=O)c12)CCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(C(=O)N2CCCCC2C)sc2nc3n(c(=O)c12)CCC3
Cc1c(C(=O)N2CCCCC2C)sc2nc3n(c(=O)c12)CCC3
4-methyl-5-(2-methylpiperidine-1-carbonyl)-6-thia-1,8-diazatricyclo[7.3.0.03,7]dodeca-3(7),4,8-trien-2-one